Page last updated: 2024-08-21

alpha-aminopyridine and Symptom Cluster

alpha-aminopyridine has been researched along with Symptom Cluster in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (40.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Cardinali, V; Cerchione, C; Falini, B; Martelli, MP; Martinelli, G; Martino, G	1
Attar, EC; de Botton, S; DiNardo, CD; Fathi, AT; Gupta, I; Kenvin, L; Kline, I; Stein, EM	1
Blot, K; Falconer, C; Marschall-Kehrel, D; Michel, MC; Radziszewski, P	1
Lundh, H; Nilsson, O; Rosén, I	1
Lang, B; Newsom-Davis, J; Wray, DW	1

Reviews

1 review(s) available for alpha-aminopyridine and Symptom Cluster

Article	Year
Enasidenib and ivosidenib in AML. Minerva medica, 2020, Volume: 111, Issue:5 Topics: Aminopyridines; Antineoplastic Agents; Cell Differentiation; Clinical Trials as Topic; Glutarates; Glycine; Humans; Isocitrate Dehydrogenase; Isocitrates; Ketoglutaric Acids; Leukemia, Myeloid, Acute; Multicenter Studies as Topic; Mutation, Missense; NADP; Pyridines; Syndrome; Triazines	2020

Trials

2 trial(s) available for alpha-aminopyridine and Symptom Cluster

Article	Year
Differentiation Syndrome Associated With Enasidenib, a Selective Inhibitor of Mutant Isocitrate Dehydrogenase 2: Analysis of a Phase 1/2 Study. JAMA oncology, 2018, 08-01, Volume: 4, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Aminopyridines; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Male; Middle Aged; Molecular Targeted Therapy; Mutation; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Syndrome; Triazines	2018
Unexpected frequent hepatotoxicity of a prescription drug, flupirtine, marketed for about 30 years. British journal of clinical pharmacology, 2012, Volume: 73, Issue:5 Topics: Aged; Aminopyridines; Analgesics; Benzhydryl Compounds; Chemical and Drug Induced Liver Injury; Cresols; Double-Blind Method; Female; Humans; Liver; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Syndrome; Tolterodine Tartrate; Urinary Bladder, Overactive	2012

Article

Year

Differentiation Syndrome Associated With Enasidenib, a Selective Inhibitor of Mutant Isocitrate Dehydrogenase 2: Analysis of a Phase 1/2 Study.

JAMA oncology, 2018, 08-01, Volume: 4, Issue:8

Topics: Adult; Aged; Aged, 80 and over; Aminopyridines; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Male; Middle Aged; Molecular Targeted Therapy; Mutation; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Syndrome; Triazines

2018

Unexpected frequent hepatotoxicity of a prescription drug, flupirtine, marketed for about 30 years.

British journal of clinical pharmacology, 2012, Volume: 73, Issue:5

Topics: Aged; Aminopyridines; Analgesics; Benzhydryl Compounds; Chemical and Drug Induced Liver Injury; Cresols; Double-Blind Method; Female; Humans; Liver; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Syndrome; Tolterodine Tartrate; Urinary Bladder, Overactive

2012

Other Studies

2 other study(ies) available for alpha-aminopyridine and Symptom Cluster

Article	Year
Treatment of Lambert-Eaton syndrome: 3,4-diaminopyridine and pyridostigmine. Neurology, 1984, Volume: 34, Issue:10 Topics: 4-Aminopyridine; Aged; Amifampridine; Aminopyridines; Autoimmune Diseases; Female; Humans; Middle Aged; Myasthenia Gravis; Pyridostigmine Bromide; Syndrome	1984
The effect of Lambert-Eaton myasthenic syndrome antibody on slow action potentials in mouse cardiac ventricle. Proceedings of the Royal Society of London. Series B, Biological sciences, 1988, Oct-22, Volume: 235, Issue:1278 Topics: 4-Aminopyridine; Action Potentials; Aminopyridines; Animals; Calcium Channels; Heart; Heart Ventricles; Humans; Immunoglobulin G; In Vitro Techniques; Mice; Neuromuscular Diseases; Reference Values; Syndrome; Tetrodotoxin; Ventricular Function; Verapamil	1988

Article

Year

Treatment of Lambert-Eaton syndrome: 3,4-diaminopyridine and pyridostigmine.

Neurology, 1984, Volume: 34, Issue:10

Topics: 4-Aminopyridine; Aged; Amifampridine; Aminopyridines; Autoimmune Diseases; Female; Humans; Middle Aged; Myasthenia Gravis; Pyridostigmine Bromide; Syndrome

1984

The effect of Lambert-Eaton myasthenic syndrome antibody on slow action potentials in mouse cardiac ventricle.

Proceedings of the Royal Society of London. Series B, Biological sciences, 1988, Oct-22, Volume: 235, Issue:1278

Topics: 4-Aminopyridine; Action Potentials; Aminopyridines; Animals; Calcium Channels; Heart; Heart Ventricles; Humans; Immunoglobulin G; In Vitro Techniques; Mice; Neuromuscular Diseases; Reference Values; Syndrome; Tetrodotoxin; Ventricular Function; Verapamil

1988